|
ASAH2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.233520E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.343900E-02 |
| Normal-vs-Stage2 |
1.078140E-02 |
| Normal-vs-Stage3 |
1.538140E-02 |
| Normal-vs-Stage4 |
5.877200E-01 |
| Stage1-vs-Stage2 |
3.742800E-01 |
| Stage1-vs-Stage3 |
6.878600E-01 |
| Stage1-vs-Stage4 |
6.869400E-01 |
| Stage2-vs-Stage3 |
6.215200E-01 |
| Stage2-vs-Stage4 |
5.506000E-01 |
| Stage3-vs-Stage4 |
6.721200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.800900E-03 |
| Normal-vs-AfricanAmerican |
1.933570E-01 |
| Normal-vs-Asian |
2.675800E-01 |
| Caucasian-vs-AfricanAmerican |
2.460800E-01 |
| Caucasian-vs-Asian |
8.469400E-01 |
| AfricanAmerican-vs-Asian |
8.042400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.08020000000264E-05 |
| Normal-vs-Female |
8.369200E-01 |
| Male-vs-Female |
7.977400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.436100E-02 |
| Normal-vs-Extreme_Weight |
1.300610E-03 |
| Normal-vs-Obese |
2.507700E-02 |
| Normal-vs-Extreme_Obese |
2.469500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.680000E-01 |
| Normal_Weight-vs-Obese |
8.306000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.171400E-01 |
| Extreme_Weight-vs-Obese |
2.197600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.525800E-01 |
| Obese-vs-Extreme_Obese |
3.430800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.774840E-01 |
| Normal-vs-Age(41-60Yrs) |
3.349600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.035560E-02 |
| Normal-vs-Age(81-100Yrs) |
4.090400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.576600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.052400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.930600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.420400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.681000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.231200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.441000E-04 |
| Normal-VS-Type2 PRCC |
1.345050E-01 |
| Normal-VS-KIRP CIMP |
5.375000E-01 |
| Normal-VS-Unclassified PRCC |
1.648430E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.878450E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.047800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.445160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.708800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.623600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.497400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.360120E-03 |
| Normal-vs-N1 |
9.593600E-02 |
| Normal-vs-N2 |
8.113200E-01 |
| N0-vs-N1 |
3.184400E-01 |
| N0-vs-N2 |
3.788400E-01 |
| N1-vs-N2 |
2.816000E-01 |
|
|
